Depomed inc stock price

DEPO - DepoMed Inc. Stock Price, Detailed Quote, and News ... DepoMed Inc. Overview: Detailed price quote, earnings report, user sentiment and news. DEPO - DepoMed Inc. Stock Price, Detailed Quote, and News - InvestorGuide.com MENU Depomed: Can Starboard Turn A Lemon Into Lemonade ... Apr 05, 2017 · Depomed share price has declined significantly in 2017 as expectations for a buyer have failed to materialize.The negative market events, slowing Nucynta sales, … DEPO - Depomed Stock Profile - Barchart.com

Depomed Inc. Announces Corporate Name Change to Assertio ...

Depomed, Inc. manufactures and distributes pharmaceutical products. It is a specialty pharmaceutical company focused on the development and commercialization of products to treat pain and other central nervous system conditions. DEPO Stock News and Price / DepoMed, Inc. - Stock Price ... DEPO / DepoMed, Inc. / ARMISTICE CAPITAL, LLC Passive Investment. 02-14 sec.gov UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Assertio Therapeutics, Inc. (formerly known as Depomed, Inc.) (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 04545L107 … Assertio Therapeutics - Wikipedia Assertio Therapeutics, Inc. (formally Depomed, Inc.) is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug

DEPO interactive stock chart | Depomed, Inc. stock - Yahoo ...

DEPO Interactive Stock Chart | Depomed, Inc. Stock - Yahoo ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. ASRT Stock Price, Forecast & News (Depomed) | MarketBeat 1 Wall Street analysts have issued 1-year price targets for Depomed's stock. Their forecasts range from $3.00 to $3.00. On average, they expect Depomed's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 372.7% from the stock's … Depomed, Inc. (delisted) Stock Quote. DEPO - Stock Price ... Depomed, Inc. (delisted) stock quote and DEPO charts. Latest stock price today and the US's most active stock market forums.